NCT05371067

Brief Summary

Fructose is increasingly present in our food. The increase in its consumption is associated with the increase in the prevalence of several pathologies such as metabolic syndrome or hepatic steatosis. The effect of fructose consumption on brain health has been poorly studied. Studies in animal models show that diets enriched in fructose promote the development of emotional behavior disorders. Fructose malabsorption is also associated with changes in the microbiota that could also impact brain health. However, no human study to date has associated fructose malabsorption with changes in the gut microbiota and effects on brain health. The objective of this study is to study the emotional behavior of a population of healthy volunteers according to the presence or not of fructose malabsorption. Patients with fructose malabsorption are susceptible to gut dysbiosis without necessarily consuming high amounts of fructose.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 8, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

January 3, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

May 12, 2022

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 16, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 16, 2022

Completed
Last Updated

May 18, 2026

Status Verified

February 1, 2026

Enrollment Period

11 months

First QC Date

January 3, 2022

Last Update Submit

May 13, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evaluate the chronic effect of fructose on anxiety in healthy volunteers with fructose malabsorption compared to healthy volunteers without fructose malabsorption.

    Spielberger State Anxiety Questionnaire Score (STAI) with 20 items rated from 1(none) to 4 (a lot).

    Day 1

Secondary Outcomes (4)

  • Evaluate the fructose consumption in healthy volunteers with fructose malabsorption compared to healthy volunteers without fructose malabsorption.

    For 7 days before day 30

  • Evaluate the chronic effect of fructose on depression in healthy volunteers with fructose malabsorption compared to healthy volunteers without fructose malabsorption.

    Day 1

  • Evaluate the chronic effect of fructose on low-grade intestinal inflammation in healthy volunteers with fructose malabsorption compared to healthy volunteers without fructose malabsorption.

    up to 1 month

  • Evaluate the chronic effect of fructose on microbiota's composition in healthy volunteers with fructose malabsorption compared to healthy volunteers without fructose malabsorption.

    up to 1 month

Study Arms (1)

Healthy volunteers

OTHER
Other: Fructose respiratory test

Interventions

Healthy volunteers will performed a fructose respiratory test in order to evaluate if they are or not fructose malabsorbing. The two population will be compared about their feelings and their micriobiote.

Healthy volunteers

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy volunteers
  • Aged 18 to 35
  • Male sex
  • BMI between 18.5 and 25
  • Affiliation to a social security scheme
  • Adult patient having read and understood the information letter and signed the consent form

You may not qualify if:

  • Presence of irritable bowel syndrome, celiac disease
  • Presence of a psychiatric illness
  • Presence of a neurodegenerative disease
  • Presence of an eating disorder
  • Presence of chronic disease, including inflammatory disease
  • Presence of diabetes
  • Presence of an acute infectious disease
  • Presence of a surgical history of the digestive tract (excluding appendectomy)
  • Taking long-term treatment
  • Taking antibiotics within 6 months
  • Taking probiotics within 3 months
  • Typical diet low in lactose, FODMAP, gluten, vegetarian, vegan, vegan, chromonutrition .... in progress
  • Smoker
  • Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection / under guardianship or guardianship
  • Simultaneous participation in another interventional clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de ROUEN

Rouen, Rouen, 76000, France

Location

Related Publications (1)

  • Coursan A, Polve D, Leroi AM, Monnoye M, Roussin L, Benatar C, Tavolacci MP, Quillard Muraine M, Maccarone M, Guerin O, Houivet E, Guerin C, Brunel V, Bellenger J, Pais de Barros JP, Gourcerol G, Naudon L, Laye S, Madore C, Fioramonti X, Melchior C, Douard V. Fructose malabsorption induces dysbiosis and increases anxiety in male human and animal models. Brain Behav Immun. 2026 Mar;133:106221. doi: 10.1016/j.bbi.2025.106221. Epub 2025 Dec 17.

MeSH Terms

Conditions

Digestive System Diseases

Study Officials

  • Chloé Melchior

    University Hospital, Rouen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: This study is a monocentric, prospective, non-randomized, comparative assay in which volontarees are enrolled in order to study the fructose effects on intestinal microbiote and their consequencies on the emotions and the neuroinflammation.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 3, 2022

First Posted

May 12, 2022

Study Start

June 8, 2021

Primary Completion

May 16, 2022

Study Completion

May 16, 2022

Last Updated

May 18, 2026

Record last verified: 2026-02

Locations